Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy

被引：0
作者：
Krabbe, L. -M. [1 ,2 ]
Krabbe, B. [3 ]
机构：
[1] Univ Klinikum Munster, Klin Urol & Kinderurol, Munster, Germany
[2] Deutsch Gesell Urol, UroEvidence, Nestorstr 8-9, D-10709 Berlin, Germany
[3] UKM Marienhosp, Abt Angiol, Steinfurt, Germany
来源：
UROLOGE | 2017年 / 56卷 / 10期
关键词：
MOLECULAR-WEIGHT HEPARIN; CELL LUNG-CANCER; PHASE-II TRIAL; ADVANCED MALIGNANCY; PANCREATIC-CANCER; CLINICAL-TRIAL; THROMBOPROPHYLAXIS; PREVENTION; DALTEPARIN; SURVIVAL;
D O I：
10.1007/s00120-017-0489-y
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1323 / 1326
页数：4
相关论文
共 24 条
[1]   Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer [J].
Agnelli, Giancarlo ;
George, Daniel J. ;
Kakkar, Ajay K. ;
Fisher, William ;
Lassen, Michael R. ;
Mismetti, Patrick ;
Mouret, Patrick ;
Chaudhari, Umesh ;
Lawson, Francesca ;
Turpie, Alexander G. G. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (07) :601-609
[2]   Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study [J].
Agnelli, Giancarlo ;
Gussoni, Gualberto ;
Bianchini, Carlo ;
Verso, Melina ;
Mandala, Mario ;
Cavanna, Luigi ;
Barni, Sandra ;
Labianca, Roberto ;
Buzzi, Franco ;
Scambia, Giovanni ;
Passalacqua, Rodolfo ;
Ricci, Sergio ;
Gasparini, Giampietro ;
Lorusso, Vito ;
Bonizzoni, Erminio ;
Tonato, Maurizio .
LANCET ONCOLOGY, 2009, 10 (10) :943-949
[3]   A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer [J].
Altinbas, M ;
Coskun, HS ;
Er, O ;
Ozkan, M ;
Eser, B ;
Unal, A ;
Cetin, M ;
Soyuer, S .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (08) :1266-1271
[4]  
[Anonymous], COCHRANE DATABASE SY
[5]   Dalteparin Low Molecular Weight Heparin (LMWH) in ovarian cancer: A phase II randomized study [J].
Elit, Laurie M. ;
Lee, Agnes Y. ;
Parpia, Sameer ;
Swystun, Laura L. ;
Liaw, Patricia C. ;
Hoskins, Paul ;
Julian, Denise H. ;
Julian, Jim A. ;
Levine, Mark N. .
THROMBOSIS RESEARCH, 2012, 130 (06) :894-900
[6]   German S3 guideline for the prevention of venous thromboembolism updated [J].
Haas, Sylvia ;
Encke, Albrecht ;
Kopp, Ina .
VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2016, 45 (05) :347-348
[7]   Low-Molecular-Weight Heparin Versus Placebo for the Prevention of Venous Thromboembolism in Metastatic Breast Cancer or Stage III/IV Lung Cancer [J].
Haas, Sylvia K. ;
Freund, Mathias ;
Heigener, David ;
Heilmann, Lothar ;
Kemkes-Matthes, Bettina ;
von Tempelhoff, Georg-Friedrich ;
Melzer, Nima ;
Kakkar, Ajay K. .
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2012, 18 (02) :159-165
[8]   Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: The fragmin advanced malignancy outcome study (FAMOUS) [J].
Kakkar, AK ;
Levine, MN ;
Kadziola, Z ;
Lemoine, NR ;
Low, V ;
Patel, HK ;
Rustin, G ;
Thomas, M ;
Quigley, M ;
Williamson, RCN .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (10) :1944-1948
[9]   Development and validation of a predictive model for chemotherapy-associated thrombosis [J].
Khorana, Alok A. ;
Kuderer, Nicole M. ;
Culakova, Eva ;
Lyman, Gary H. ;
Francis, Charles W. .
BLOOD, 2008, 111 (10) :4902-4907
[10]   The wacky hypercoagulable state of malignancy [J].
Khorana, Alok A. .
BLOOD, 2015, 126 (04) :430-431
123